Difference between revisions of "Medulloblastoma"

From Compendium of Cancer Genome Aberrations
Jump to navigation Jump to search
[unchecked revision][unchecked revision]
(Created page with "test")
 
 
Line 1: Line 1:
test
+
__TOC__
 +
 
 +
== Contributors ==
 +
 
 +
Write your comments here
 +
 
 +
== Tumor Type ==
 +
 
 +
Write your comments here <ref>Test Reference: Nowell and Hungerford (1962). Chromosome studies in human leukemia. IV. Myeloproliferative syndrome and other atypical myeloid disorders. ''J Natl Cancer Inst'' 29:911-31 PMID:[http://www.ncbi.nlm.nih.gov/pubmed/?term=13939164 13939164] </ref>
 +
 
 +
== Tumor Classification ==
 +
 
 +
Write your comments here
 +
 
 +
== Description ==
 +
 
 +
Write your comments here
 +
 
 +
== IHC Markers ==
 +
 
 +
Write your comments here
 +
 
 +
== Genomic Gain/Loss/LOH ==
 +
 
 +
Write your comments here
 +
 
 +
== Rearrangements ==
 +
 
 +
Write your comments here
 +
 
 +
== Mutations (SNV/INDEL) ==
 +
 
 +
Write your comments here
 +
 
 +
=== From Cosmic Mutated in >20% ===
 +
=== Mutated in 10-20% ===
 +
=== Mutated in 5-10% ===
 +
=== Mutated in 2-5% ===
 +
=== mtDNA ===
 +
 
 +
== Epigenomics (methylation) ==
 +
 
 +
Write your comments here
 +
 
 +
== Main Pathways Involved ==
 +
 
 +
Write your comments here
 +
 
 +
== Clinical Significance ==
 +
 
 +
Write your comments here
 +
 
 +
== Diagnosis ==
 +
 
 +
Write your comments here
 +
 
 +
== Prognosis ==
 +
 
 +
Write your comments here
 +
 
 +
== Therapeutics ==
 +
 
 +
Write your comments here
 +
 
 +
== Familial Forms ==
 +
 
 +
Write your comments here
 +
 
 +
==References==
 +
{{Reflist}}

Latest revision as of 15:07, 24 February 2016

Contributors

Write your comments here

Tumor Type

Write your comments here [1]

Tumor Classification

Write your comments here

Description

Write your comments here

IHC Markers

Write your comments here

Genomic Gain/Loss/LOH

Write your comments here

Rearrangements

Write your comments here

Mutations (SNV/INDEL)

Write your comments here

From Cosmic Mutated in >20%

Mutated in 10-20%

Mutated in 5-10%

Mutated in 2-5%

mtDNA

Epigenomics (methylation)

Write your comments here

Main Pathways Involved

Write your comments here

Clinical Significance

Write your comments here

Diagnosis

Write your comments here

Prognosis

Write your comments here

Therapeutics

Write your comments here

Familial Forms

Write your comments here

References

  1. Test Reference: Nowell and Hungerford (1962). Chromosome studies in human leukemia. IV. Myeloproliferative syndrome and other atypical myeloid disorders. J Natl Cancer Inst 29:911-31 PMID:13939164